Inventor · disambiguated record
Xavier Anguela
Also filed as: ANGUELA XAVIER
11 granted patents·17 pending applications·121 citations·filing 2012–2024
88Inventor score
Files withSPARK THERAPEUTICS INC17CHILDRENS HOSPITAL PHILADELPHIA10THE CHILDREN'S HOSPITAL OF PHILADELPHIA1
Top patents by PatentIndex Score
28 records- 0196US9840719B2Variant AAV and compositions, methods and uses for gene transfer to cells, organs and tissuesTHE CHILDREN'S HOSPITAL OF PHILADELPHIA·Filed 2014·Granted Dec 12, 2017·86 cites·21 claims
- 0295US11110153B2Modified factor IX, and compositions, methods and uses for gene transfer to cells, organs, and tissuesCHILDRENS HOSPITAL PHILADELPHIA·Filed 2020·Granted Sep 7, 2021·3 cites·28 claims
- 0393US10799566B2Modified factor IX, and compositions, methods and uses for gene transfer to cells, organs, and tissuesCHILDRENS HOSPITAL PHILADELPHIA·Filed 2016·Granted Oct 13, 2020·7 cites·64 claims
- 0492US9909142B2Composition and methods for highly efficient gene transfer using AAV capsid variantsCHILDRENS HOSPITAL PHILADELPHIA·Filed 2013·Granted Mar 6, 2018·24 cites·19 claims
- 0590US11491213B2Modified factor IX, and compositions, methods and uses for gene transfer to cells, organs, and tissuesCHILDRENS HOSPITAL PHILADELPHIA·Filed 2021·Granted Nov 8, 2022·1 cites·33 claims
- 0685US2024131126A1Modified factor ix, and compositions, methods and uses for gene transfer to cells, organs, and tissuesCHILDRENS HOSPITAL PHILADELPHIA·Filed 2023·Application pending·0 cites
- 0783US11896652B2Modified factor IX, and compositions, methods and uses for gene transfer to cells, organs, and tissuesCHILDRENS HOSPITAL PHILADELPHIA·Filed 2022·Granted Feb 13, 2024·0 cites·23 claims
- 0876US2020129598A1Modified factor ix, and compositions, methods and uses for gene transfer to cells, organs, and tissuesCHILDRENS HOSPITAL PHILADELPHIA·Filed 2019·Application pending·0 cites
- 0975US2025171521A1CpG REDUCED FACTOR VIII VARIANTS, COMPOSITIONS AND METHODS AND USES FOR TREATMENT OF HEMOSTASIS DISORDERSSPARK THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1072US2022387560A1Adeno-Associated Virus-Mediated CRISPR-Cas9 Treatment of Ocular DiseaseSPARK THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1166US2025073353A1Factor viii (fviii) gene therapy methodsSPARK THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1266US2025101396A1Codon-optimized acid alpha-glucosidase expression cassettes and methods of using sameSPARK THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1362US2019038724A1Adeno-Associated Virus-Mediated CRISPR-Cas9 Treatment of Ocular DiseaseSPARK THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1461US11279950B2Composition and methods for highly efficient gene transfer using AAV capsid variantsCHILDRENS HOSPITAL PHILADELPHIA·Filed 2018·Granted Mar 22, 2022·0 cites·17 claims
- 1561US11168124B2CpG reduced factor VIII variants, compositions and methods and uses for treatment of hemostasis disordersSPARK THERAPEUTICS INC·Filed 2017·Granted Nov 9, 2021·0 cites·41 claims
- 1657US2025228928A1Immune enhancement and infectious disease treatmentSPARK THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1756US12290574B2Optimized promoter sequences, intron-free expression constructs and methods of useSPARK THERAPEUTICS INC·Filed 2019·Granted May 6, 2025·0 cites·35 claims
- 1856US12084693B2Codon-optimized acid alpha-glucosidase expression cassettes and methods of using sameSPARK THERAPEUTICS INC·Filed 2019·Granted Sep 10, 2024·0 cites·40 claims
- 1956US2025221932A1Immune enhancement of cancer treatmentSPARK THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2055US2024074986A1Methods of Enhancing Non-Viral Gene TherapySPARK THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2155US2016346359A1Adeno-associated Virus-Mediated CRISPR-Cas9 Treatment of Ocular DiseaseSPARK THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2253US2018187213A1Variant AAV and Compositions, Methods and Uses for Gene Transfer to Cells, Organs and TissuesCHILDRENS HOSPITAL PHILADELPHIA·Filed 2017·Application pending·0 cites
- 2350US2021371877A1Adeno-associated virus (aav) vector lipid nanoparticle compositions and methods of useSPARK THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2445US2018312571A1CpG REDUCED FACTOR VIII VARIANTS, COMPOSITIONS AND METHODS AND USES FOR TREATMENT OF HEMOSTASIS DISORDERSSPARK THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2545US2022011308A1In vitro assay for detecting enhancers and inhibitors of adeno associated virus (aav) vector transduction and/or detecting or quantitating anti-aav binding antibodiesSPARK THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2645US2020237930A1Factor viii (fviii) gene therapy methodsSPARK THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2740US10640785B2Virus vectors for highly efficient transgene deliveryCHILDRENS HOSPITAL PHILADELPHIA·Filed 2012·Granted May 5, 2020·0 cites·28 claims
- 2839US2021363192A1Engineered aav capsids with increased tropism and aav vectors comprising the engineered capsids and methods of making and using sameSPARK THERAPEUTICS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xavier Anguela files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →